

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 9.36552492 |
| 2 | doxorubicin metabolic process (GO:0044598) | 9.36552492 |
| 3 | daunorubicin metabolic process (GO:0044597) | 9.36552492 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.05163846 |
| 5 | maintenance of protein location in nucleus (GO:0051457) | 5.97712965 |
| 6 | regulation of response to osmotic stress (GO:0047484) | 5.34772159 |
| 7 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.48885013 |
| 8 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.47842454 |
| 9 | interferon-gamma production (GO:0032609) | 4.38395696 |
| 10 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.33572437 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.33572437 |
| 12 | cytidine metabolic process (GO:0046087) | 4.28609292 |
| 13 | cytidine catabolic process (GO:0006216) | 4.28609292 |
| 14 | cytidine deamination (GO:0009972) | 4.28609292 |
| 15 | somite rostral/caudal axis specification (GO:0032525) | 4.27999003 |
| 16 | muscle organ morphogenesis (GO:0048644) | 4.25399880 |
| 17 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.19942458 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.19399344 |
| 19 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.13473220 |
| 20 | regulation of T-helper 2 cell differentiation (GO:0045628) | 4.06202492 |
| 21 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.04556171 |
| 22 | immunoglobulin mediated immune response (GO:0016064) | 3.99512017 |
| 23 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.86122129 |
| 24 | negative regulation of epidermis development (GO:0045683) | 3.83925222 |
| 25 | nucleoside transmembrane transport (GO:1901642) | 3.82819553 |
| 26 | response to dietary excess (GO:0002021) | 3.82438928 |
| 27 | hormone catabolic process (GO:0042447) | 3.79788202 |
| 28 | positive thymic T cell selection (GO:0045059) | 3.79149586 |
| 29 | positive regulation of defense response to virus by host (GO:0002230) | 3.76666745 |
| 30 | leukocyte aggregation (GO:0070486) | 3.75724693 |
| 31 | regulation of telomere maintenance via telomerase (GO:0032210) | 3.73053516 |
| 32 | rRNA transcription (GO:0009303) | 3.72693404 |
| 33 | coenzyme catabolic process (GO:0009109) | 3.72361613 |
| 34 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 3.68519673 |
| 35 | negative regulation of telomerase activity (GO:0051974) | 3.65927127 |
| 36 | establishment of endothelial barrier (GO:0061028) | 3.65636253 |
| 37 | phagocytosis, recognition (GO:0006910) | 3.54556301 |
| 38 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.51984674 |
| 39 | detection of other organism (GO:0098543) | 3.50675050 |
| 40 | detection of bacterium (GO:0016045) | 3.50334803 |
| 41 | negative regulation of viral release from host cell (GO:1902187) | 3.47872762 |
| 42 | mannose metabolic process (GO:0006013) | 3.40266385 |
| 43 | regulation of gamma-delta T cell activation (GO:0046643) | 3.36719335 |
| 44 | neutrophil activation involved in immune response (GO:0002283) | 3.36166923 |
| 45 | positive regulation of protein deacetylation (GO:0090312) | 3.33166229 |
| 46 | maintenance of protein localization in organelle (GO:0072595) | 3.32286891 |
| 47 | axon ensheathment in central nervous system (GO:0032291) | 3.32182860 |
| 48 | central nervous system myelination (GO:0022010) | 3.32182860 |
| 49 | histone H4-K12 acetylation (GO:0043983) | 3.31628458 |
| 50 | positive regulation of macrophage cytokine production (GO:0060907) | 3.29567239 |
| 51 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.28078732 |
| 52 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.26313972 |
| 53 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.26151488 |
| 54 | NIK/NF-kappaB signaling (GO:0038061) | 3.24813141 |
| 55 | quinone metabolic process (GO:1901661) | 3.24295510 |
| 56 | macrophage activation involved in immune response (GO:0002281) | 3.23037527 |
| 57 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.20641353 |
| 58 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.20382910 |
| 59 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.20076321 |
| 60 | histone H4-K8 acetylation (GO:0043982) | 3.18930002 |
| 61 | histone H4-K5 acetylation (GO:0043981) | 3.18930002 |
| 62 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.17923402 |
| 63 | response to muramyl dipeptide (GO:0032495) | 3.17716395 |
| 64 | positive regulation of tissue remodeling (GO:0034105) | 3.15842073 |
| 65 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.15803652 |
| 66 | thymic T cell selection (GO:0045061) | 3.12041324 |
| 67 | barbed-end actin filament capping (GO:0051016) | 3.11386768 |
| 68 | positive regulation of interleukin-17 production (GO:0032740) | 3.10578430 |
| 69 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.09916449 |
| 70 | regulation of translation in response to stress (GO:0043555) | 3.09064559 |
| 71 | negative regulation of interleukin-12 production (GO:0032695) | 3.08690894 |
| 72 | regulation of leukocyte degranulation (GO:0043300) | 3.08105629 |
| 73 | membrane protein intracellular domain proteolysis (GO:0031293) | 3.06961641 |
| 74 | protein localization to kinetochore (GO:0034501) | 3.05334042 |
| 75 | regulation of mast cell degranulation (GO:0043304) | 3.05063621 |
| 76 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 3.04623017 |
| 77 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.02830782 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.02059394 |
| 79 | Rap protein signal transduction (GO:0032486) | 3.01800569 |
| 80 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.01565869 |
| 81 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.01128313 |
| 82 | response to peptidoglycan (GO:0032494) | 3.00404101 |
| 83 | icosanoid secretion (GO:0032309) | 3.00318295 |
| 84 | arachidonic acid secretion (GO:0050482) | 3.00318295 |
| 85 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.99562511 |
| 86 | germinal center formation (GO:0002467) | 2.99057320 |
| 87 | cofactor transport (GO:0051181) | 2.98949257 |
| 88 | mitochondrion distribution (GO:0048311) | 2.98080552 |
| 89 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.95369562 |
| 90 | detection of external biotic stimulus (GO:0098581) | 2.95326436 |
| 91 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.95309936 |
| 92 | retinoic acid receptor signaling pathway (GO:0048384) | 2.91880981 |
| 93 | hypotonic response (GO:0006971) | 2.91771024 |
| 94 | primary alcohol catabolic process (GO:0034310) | 2.91335900 |
| 95 | myelin maintenance (GO:0043217) | 2.90745246 |
| 96 | positive regulation of histone deacetylation (GO:0031065) | 2.90515257 |
| 97 | cofactor catabolic process (GO:0051187) | 2.89855983 |
| 98 | transepithelial transport (GO:0070633) | 2.87512756 |
| 99 | negative regulation of interleukin-2 production (GO:0032703) | 2.87476139 |
| 100 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.87437714 |
| 101 | cyclooxygenase pathway (GO:0019371) | 2.86183976 |
| 102 | heme transport (GO:0015886) | 2.86134195 |
| 103 | detection of temperature stimulus (GO:0016048) | 2.85476054 |
| 104 | negative thymic T cell selection (GO:0045060) | 2.84891612 |
| 105 | positive regulation of odontogenesis (GO:0042482) | 2.83869391 |
| 106 | B cell mediated immunity (GO:0019724) | 2.83454474 |
| 107 | regulation of extracellular matrix disassembly (GO:0010715) | 2.81720120 |
| 108 | response to laminar fluid shear stress (GO:0034616) | 2.80656205 |
| 109 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.80446006 |
| 110 | endothelial cell development (GO:0001885) | 2.79902299 |
| 111 | tachykinin receptor signaling pathway (GO:0007217) | 2.79188357 |
| 112 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.77958971 |
| 113 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.77548047 |
| 114 | positive regulation of type 2 immune response (GO:0002830) | 2.77239822 |
| 115 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.76989349 |
| 116 | T cell selection (GO:0045058) | 2.75818558 |
| 117 | regulation of type 2 immune response (GO:0002828) | 2.75197514 |
| 118 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.75053058 |
| 119 | COPI coating of Golgi vesicle (GO:0048205) | 2.74245151 |
| 120 | Golgi transport vesicle coating (GO:0048200) | 2.74245151 |
| 121 | natural killer cell differentiation (GO:0001779) | 2.73871338 |
| 122 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.73829611 |
| 123 | positive T cell selection (GO:0043368) | 2.72959775 |
| 124 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.72745601 |
| 125 | regulation of cilium movement (GO:0003352) | 2.71639134 |
| 126 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.70611975 |
| 127 | adaptation of signaling pathway (GO:0023058) | 2.70487062 |
| 128 | amino sugar catabolic process (GO:0046348) | 2.69954494 |
| 129 | positive regulation by symbiont of host defense response (GO:0052509) | 2.69089944 |
| 130 | modulation by symbiont of host defense response (GO:0052031) | 2.69089944 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.69089944 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.69089944 |
| 133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.69089944 |
| 134 | modulation by symbiont of host immune response (GO:0052553) | 2.69089944 |
| 135 | nucleoside transport (GO:0015858) | 2.68928660 |
| 136 | virion attachment to host cell (GO:0019062) | 2.66898852 |
| 137 | adhesion of symbiont to host cell (GO:0044650) | 2.66898852 |
| 138 | cellular response to type I interferon (GO:0071357) | 2.66102070 |
| 139 | type I interferon signaling pathway (GO:0060337) | 2.66102070 |
| 140 | response to type I interferon (GO:0034340) | 2.65902637 |
| 141 | pinocytosis (GO:0006907) | 2.64494514 |
| 142 | negative regulation of type 2 immune response (GO:0002829) | 2.63813072 |
| 143 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.63589493 |
| 144 | neutrophil activation (GO:0042119) | 2.63328837 |
| 145 | protein localization to endosome (GO:0036010) | 2.62475870 |
| 146 | positive regulation of developmental pigmentation (GO:0048087) | 2.62224481 |
| 147 | amyloid precursor protein catabolic process (GO:0042987) | 2.60845350 |
| 148 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60750419 |
| 149 | ensheathment of neurons (GO:0007272) | 2.60413005 |
| 150 | modulation by virus of host process (GO:0019054) | 2.60222582 |
| 151 | granulocyte activation (GO:0036230) | 2.60091684 |
| 152 | modulation by symbiont of host cellular process (GO:0044068) | 2.59937602 |
| 153 | negative T cell selection (GO:0043383) | 2.59877321 |
| 154 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.59544206 |
| 155 | tolerance induction (GO:0002507) | 2.59352844 |
| 156 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57140884 |
| 157 | negative regulation of granulocyte differentiation (GO:0030853) | 2.55813284 |
| 158 | regulation of superoxide anion generation (GO:0032928) | 2.55649386 |
| 159 | myeloid dendritic cell differentiation (GO:0043011) | 2.55521725 |
| 160 | glycosphingolipid catabolic process (GO:0046479) | 2.55281418 |
| 161 | detection of molecule of bacterial origin (GO:0032490) | 2.53650477 |
| 162 | regulation of necroptotic process (GO:0060544) | 2.52914020 |
| 163 | regulation of defense response to virus by virus (GO:0050690) | 2.51499029 |
| 164 | regulation of ARF GTPase activity (GO:0032312) | 2.51319649 |
| 165 | detection of biotic stimulus (GO:0009595) | 2.50694740 |
| 166 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.50035308 |
| 167 | negative regulation of innate immune response (GO:0045824) | 2.49677216 |
| 168 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.49017786 |
| 169 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.47573646 |
| 170 | regulation of regulated secretory pathway (GO:1903305) | 2.44845846 |
| 171 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.44485094 |
| 172 | regulation of somitogenesis (GO:0014807) | 2.44181128 |
| 173 | signal complex assembly (GO:0007172) | 2.44154751 |
| 174 | regulation of necrotic cell death (GO:0010939) | 2.44138177 |
| 175 | negative regulation of cell size (GO:0045792) | 2.43590639 |
| 176 | response to host immune response (GO:0052572) | 2.41198658 |
| 177 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.41198658 |
| 178 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.40532644 |
| 179 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.40371130 |
| 180 | response to host defenses (GO:0052200) | 2.38822471 |
| 181 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.38822471 |
| 182 | response to host (GO:0075136) | 2.38822471 |
| 183 | respiratory burst (GO:0045730) | 2.35076913 |
| 184 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.34684864 |
| 185 | pentose-phosphate shunt (GO:0006098) | 2.34655191 |
| 186 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.34218354 |
| 187 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.33810021 |
| 188 | stress granule assembly (GO:0034063) | 2.33587359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.31635665 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.09619130 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.09619130 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.09619130 |
| 5 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.22802654 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.11367635 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.36965428 |
| 8 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.22908546 |
| 9 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.15068240 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13883946 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.09261127 |
| 12 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.07697643 |
| 13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.07312547 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.07112772 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.04409668 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.96580144 |
| 17 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.94845519 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.94631091 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.92230595 |
| 20 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.86077890 |
| 21 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85554263 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.81721265 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.77622574 |
| 24 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.76694201 |
| 25 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.75114322 |
| 26 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.74563028 |
| 27 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.66676238 |
| 28 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.59020373 |
| 29 | * P68_20966046_ChIP-Seq_HELA_Human | 1.56713502 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.54663906 |
| 31 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.54158245 |
| 32 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53431794 |
| 33 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.53152642 |
| 34 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.51670563 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.51578034 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.50616441 |
| 37 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50491048 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50066787 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.49031511 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.47212199 |
| 41 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.45336811 |
| 42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44743252 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.44505099 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43791506 |
| 45 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.43746542 |
| 46 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43630355 |
| 47 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.42880259 |
| 48 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42815010 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42534385 |
| 50 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.42004651 |
| 51 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.40167738 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38286624 |
| 53 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.37961976 |
| 54 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.37641862 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.37306944 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36311132 |
| 57 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36137331 |
| 58 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.34795441 |
| 59 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.33550065 |
| 60 | MYC_22102868_ChIP-Seq_BL_Human | 1.33454473 |
| 61 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.33224740 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33180606 |
| 63 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.33107802 |
| 64 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.32736287 |
| 65 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32405929 |
| 66 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31390097 |
| 67 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.31382419 |
| 68 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.31207298 |
| 69 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29509905 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.29298484 |
| 71 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29194829 |
| 72 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29073467 |
| 73 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.28996804 |
| 74 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27229200 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.25358367 |
| 76 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.25307870 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25168298 |
| 78 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24708374 |
| 79 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24693896 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22528517 |
| 81 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.20103705 |
| 82 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.20086272 |
| 83 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.19981183 |
| 84 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19273246 |
| 85 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.19260475 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17936173 |
| 87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17371764 |
| 88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.15347573 |
| 89 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.15212532 |
| 90 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14097321 |
| 91 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13332179 |
| 92 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12519279 |
| 93 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.11947189 |
| 94 | MAF_26560356_Chip-Seq_TH1_Human | 1.10218728 |
| 95 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.10034180 |
| 96 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08506098 |
| 97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08397652 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07664459 |
| 99 | GATA1_19941826_ChIP-Seq_K562_Human | 1.07434156 |
| 100 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07255541 |
| 101 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06873450 |
| 102 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.05678774 |
| 103 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.04957341 |
| 104 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04923470 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.04203014 |
| 106 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03786314 |
| 107 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.03750301 |
| 108 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03313420 |
| 109 | ATF3_27146783_Chip-Seq_COLON_Human | 1.03132380 |
| 110 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.02428616 |
| 111 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.01915928 |
| 112 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01836070 |
| 113 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01742856 |
| 114 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01651594 |
| 115 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.00569850 |
| 116 | MYB_26560356_Chip-Seq_TH1_Human | 1.00257972 |
| 117 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99821898 |
| 118 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.99457271 |
| 119 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 0.97799024 |
| 120 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.97532173 |
| 121 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97220716 |
| 122 | MYB_26560356_Chip-Seq_TH2_Human | 0.96265952 |
| 123 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.96250060 |
| 124 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95399420 |
| 125 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.94433070 |
| 126 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93884819 |
| 127 | * TP53_22127205_ChIP-Seq_IMR90_Human | 0.93809909 |
| 128 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.93511278 |
| 129 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.92700301 |
| 130 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91052889 |
| 131 | UTX_26944678_Chip-Seq_JUKART_Human | 0.88226965 |
| 132 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.87401321 |
| 133 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 0.87396514 |
| 134 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.87196576 |
| 135 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86636557 |
| 136 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.86206822 |
| 137 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 0.84871017 |
| 138 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.84663902 |
| 139 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84212375 |
| 140 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84129215 |
| 141 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.83833471 |
| 142 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83689251 |
| 143 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.83082865 |
| 144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.81918140 |
| 145 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.80959418 |
| 146 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80899074 |
| 147 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.78984242 |
| 148 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.78294228 |
| 149 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76665292 |
| 150 | MAF_26560356_Chip-Seq_TH2_Human | 0.76549523 |
| 151 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76191291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 4.05740067 |
| 2 | MP0003011_delayed_dark_adaptation | 3.91807175 |
| 3 | MP0004858_abnormal_nervous_system | 3.48522453 |
| 4 | MP0002254_reproductive_system_inflammat | 3.24453078 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.08394833 |
| 6 | MP0005075_abnormal_melanosome_morpholog | 3.01668357 |
| 7 | MP0005451_abnormal_body_composition | 2.95639517 |
| 8 | MP0008260_abnormal_autophagy | 2.89490190 |
| 9 | MP0002332_abnormal_exercise_endurance | 2.67462708 |
| 10 | MP0003300_gastrointestinal_ulcer | 2.61593287 |
| 11 | MP0009278_abnormal_bone_marrow | 2.55492323 |
| 12 | MP0003183_abnormal_peptide_metabolism | 2.38642724 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.38003006 |
| 14 | MP0009840_abnormal_foam_cell | 2.35966641 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.28960284 |
| 16 | MP0000920_abnormal_myelination | 2.14192092 |
| 17 | MP0001790_abnormal_immune_system | 2.07116921 |
| 18 | MP0005387_immune_system_phenotype | 2.07116921 |
| 19 | MP0003436_decreased_susceptibility_to | 2.05055448 |
| 20 | MP0009785_altered_susceptibility_to | 2.00583174 |
| 21 | MP0004510_myositis | 1.94512013 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.91163462 |
| 23 | MP0003172_abnormal_lysosome_physiology | 1.91015643 |
| 24 | MP0005025_abnormal_response_to | 1.86460495 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.84350215 |
| 26 | MP0003763_abnormal_thymus_physiology | 1.80879177 |
| 27 | MP0005671_abnormal_response_to | 1.79484536 |
| 28 | MP0003950_abnormal_plasma_membrane | 1.75959625 |
| 29 | MP0002148_abnormal_hypersensitivity_rea | 1.73408559 |
| 30 | MP0000343_altered_response_to | 1.69609065 |
| 31 | MP0008057_abnormal_DNA_replication | 1.68562804 |
| 32 | MP0001800_abnormal_humoral_immune | 1.66723519 |
| 33 | MP0005394_taste/olfaction_phenotype | 1.64914523 |
| 34 | MP0005499_abnormal_olfactory_system | 1.64914523 |
| 35 | MP0000685_abnormal_immune_system | 1.62607624 |
| 36 | MP0002419_abnormal_innate_immunity | 1.61750113 |
| 37 | MP0003075_altered_response_to | 1.60170253 |
| 38 | MP0002396_abnormal_hematopoietic_system | 1.59802036 |
| 39 | MP0006292_abnormal_olfactory_placode | 1.58093153 |
| 40 | MP0002723_abnormal_immune_serum | 1.57675597 |
| 41 | MP0003690_abnormal_glial_cell | 1.56647097 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.54246316 |
| 43 | MP0005257_abnormal_intraocular_pressure | 1.54114282 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.53878266 |
| 45 | MP0003890_abnormal_embryonic-extraembry | 1.52017557 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.45812096 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.45812096 |
| 48 | MP0001819_abnormal_immune_cell | 1.44921280 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.44632346 |
| 50 | MP0002405_respiratory_system_inflammati | 1.43343778 |
| 51 | MP0003329_amyloid_beta_deposits | 1.41708676 |
| 52 | MP0002277_abnormal_respiratory_mucosa | 1.40696486 |
| 53 | MP0001849_ear_inflammation | 1.36988620 |
| 54 | MP0002653_abnormal_ependyma_morphology | 1.36334779 |
| 55 | MP0003448_altered_tumor_morphology | 1.33430988 |
| 56 | MP0006035_abnormal_mitochondrial_morpho | 1.33335742 |
| 57 | MP0010352_gastrointestinal_tract_polyps | 1.29613169 |
| 58 | MP0004043_abnormal_pH_regulation | 1.29142098 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.29128833 |
| 60 | MP0005310_abnormal_salivary_gland | 1.28983547 |
| 61 | MP0002933_joint_inflammation | 1.27621476 |
| 62 | MP0005023_abnormal_wound_healing | 1.25260748 |
| 63 | MP0005076_abnormal_cell_differentiation | 1.20700554 |
| 64 | MP0001873_stomach_inflammation | 1.20561675 |
| 65 | MP0003122_maternal_imprinting | 1.19707883 |
| 66 | MP0000716_abnormal_immune_system | 1.19350491 |
| 67 | MP0000689_abnormal_spleen_morphology | 1.15749384 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.15732218 |
| 69 | MP0003303_peritoneal_inflammation | 1.15054635 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 1.14018002 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.12150652 |
| 72 | MP0004381_abnormal_hair_follicle | 1.11828676 |
| 73 | MP0003828_pulmonary_edema | 1.11279670 |
| 74 | MP0000604_amyloidosis | 1.10534613 |
| 75 | MP0009764_decreased_sensitivity_to | 1.08635044 |
| 76 | MP0002429_abnormal_blood_cell | 1.07731431 |
| 77 | MP0003938_abnormal_ear_development | 1.07147973 |
| 78 | MP0010155_abnormal_intestine_physiology | 1.06350696 |
| 79 | MP0003866_abnormal_defecation | 1.03415965 |
| 80 | MP0004947_skin_inflammation | 1.02962696 |
| 81 | MP0002127_abnormal_cardiovascular_syste | 1.02681761 |
| 82 | MP0003634_abnormal_glial_cell | 1.02591710 |
| 83 | MP0003279_aneurysm | 1.01256420 |
| 84 | MP0008469_abnormal_protein_level | 1.00554847 |
| 85 | MP0002722_abnormal_immune_system | 0.99454022 |
| 86 | MP0003091_abnormal_cell_migration | 0.99108144 |
| 87 | MP0001845_abnormal_inflammatory_respons | 0.98101212 |
| 88 | MP0002398_abnormal_bone_marrow | 0.97946836 |
| 89 | MP0003186_abnormal_redox_activity | 0.97679350 |
| 90 | MP0000678_abnormal_parathyroid_gland | 0.95893495 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 0.95829966 |
| 92 | MP0000749_muscle_degeneration | 0.95448807 |
| 93 | MP0002092_abnormal_eye_morphology | 0.95166545 |
| 94 | MP0001348_abnormal_lacrimal_gland | 0.94085153 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.93192430 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.93052338 |
| 97 | MP0005266_abnormal_metabolism | 0.92869839 |
| 98 | MP0000490_abnormal_crypts_of | 0.90919842 |
| 99 | MP0005164_abnormal_response_to | 0.90223791 |
| 100 | MP0001853_heart_inflammation | 0.90067735 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.89652404 |
| 102 | MP0003724_increased_susceptibility_to | 0.89593730 |
| 103 | MP0008874_decreased_physiological_sensi | 0.88436500 |
| 104 | MP0001293_anophthalmia | 0.87647155 |
| 105 | MP0003453_abnormal_keratinocyte_physiol | 0.86789306 |
| 106 | MP0002877_abnormal_melanocyte_morpholog | 0.86455408 |
| 107 | MP0002132_abnormal_respiratory_system | 0.86245439 |
| 108 | MP0005166_decreased_susceptibility_to | 0.86014703 |
| 109 | MP0000858_altered_metastatic_potential | 0.84865770 |
| 110 | MP0003984_embryonic_growth_retardation | 0.84345159 |
| 111 | MP0002088_abnormal_embryonic_growth/wei | 0.84310314 |
| 112 | MP0003795_abnormal_bone_structure | 0.83640484 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.82563260 |
| 114 | MP0003656_abnormal_erythrocyte_physiolo | 0.82051222 |
| 115 | MP0004883_abnormal_blood_vessel | 0.82017190 |
| 116 | MP0001851_eye_inflammation | 0.81731864 |
| 117 | MP0004957_abnormal_blastocyst_morpholog | 0.81395947 |
| 118 | MP0001672_abnormal_embryogenesis/_devel | 0.81199571 |
| 119 | MP0005380_embryogenesis_phenotype | 0.81199571 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.78532191 |
| 121 | MP0001958_emphysema | 0.76847893 |
| 122 | MP0000383_abnormal_hair_follicle | 0.74433673 |
| 123 | MP0002089_abnormal_postnatal_growth/wei | 0.72036996 |
| 124 | MP0008004_abnormal_stomach_pH | 0.71953538 |
| 125 | MP0005464_abnormal_platelet_physiology | 0.70495738 |
| 126 | MP0000249_abnormal_blood_vessel | 0.69880271 |
| 127 | MP0005375_adipose_tissue_phenotype | 0.69099939 |
| 128 | MP0008961_abnormal_basal_metabolism | 0.68097868 |
| 129 | MP0005390_skeleton_phenotype | 0.67973887 |
| 130 | MP0000751_myopathy | 0.67198259 |
| 131 | MP0000313_abnormal_cell_death | 0.66990180 |
| 132 | MP0002998_abnormal_bone_remodeling | 0.66806681 |
| 133 | MP0002166_altered_tumor_susceptibility | 0.66620122 |
| 134 | MP0003566_abnormal_cell_adhesion | 0.66395125 |
| 135 | MP0009931_abnormal_skin_appearance | 0.66059200 |
| 136 | MP0002796_impaired_skin_barrier | 0.65213914 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 5.97222667 |
| 2 | Multiple enchondromatosis (HP:0005701) | 4.69398131 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 4.65293461 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.64478177 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.64478177 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.64478177 |
| 7 | Partial duplication of thumb phalanx (HP:0009944) | 3.86352912 |
| 8 | Hepatoblastoma (HP:0002884) | 3.84841830 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.60748218 |
| 10 | Rib fusion (HP:0000902) | 3.54119334 |
| 11 | Dysostosis multiplex (HP:0000943) | 3.43996280 |
| 12 | Abnormality of the lower motor neuron (HP:0002366) | 3.28530971 |
| 13 | Partial duplication of the phalanx of hand (HP:0009999) | 3.27589456 |
| 14 | Rectovaginal fistula (HP:0000143) | 3.23095118 |
| 15 | Rectal fistula (HP:0100590) | 3.23095118 |
| 16 | Testicular atrophy (HP:0000029) | 3.13696977 |
| 17 | Sensory axonal neuropathy (HP:0003390) | 3.09662743 |
| 18 | Fused cervical vertebrae (HP:0002949) | 3.08520279 |
| 19 | Recurrent abscess formation (HP:0002722) | 3.07721095 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 3.05175554 |
| 21 | Abnormality of the salivary glands (HP:0010286) | 3.00949076 |
| 22 | Increased IgE level (HP:0003212) | 2.95199852 |
| 23 | Intestinal fistula (HP:0100819) | 2.94120975 |
| 24 | Anomalous pulmonary venous return (HP:0010772) | 2.93530074 |
| 25 | Vacuolated lymphocytes (HP:0001922) | 2.93065681 |
| 26 | Nasal polyposis (HP:0100582) | 2.90051573 |
| 27 | Hypoplasia of the fovea (HP:0007750) | 2.89839166 |
| 28 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.89839166 |
| 29 | Abnormality of the nasal mucosa (HP:0000433) | 2.89103161 |
| 30 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.88893081 |
| 31 | Vaginal fistula (HP:0004320) | 2.87826955 |
| 32 | Eczematoid dermatitis (HP:0000976) | 2.85021924 |
| 33 | Increased cerebral lipofuscin (HP:0011813) | 2.84330843 |
| 34 | Axonal loss (HP:0003447) | 2.80179178 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.75177336 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.75177336 |
| 37 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.75177336 |
| 38 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.73606248 |
| 39 | Spastic tetraparesis (HP:0001285) | 2.71887705 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.64983870 |
| 41 | Recurrent bacterial skin infections (HP:0005406) | 2.63039837 |
| 42 | Upper motor neuron abnormality (HP:0002127) | 2.63021588 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.61348030 |
| 44 | Mucopolysacchariduria (HP:0008155) | 2.61348030 |
| 45 | Abnormality of the pulmonary veins (HP:0011718) | 2.61283023 |
| 46 | Pustule (HP:0200039) | 2.61173316 |
| 47 | Ependymoma (HP:0002888) | 2.61170712 |
| 48 | Mediastinal lymphadenopathy (HP:0100721) | 2.59176717 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59111459 |
| 50 | Chronic obstructive pulmonary disease (HP:0006510) | 2.56598888 |
| 51 | Obstructive lung disease (HP:0006536) | 2.56598888 |
| 52 | Interstitial pulmonary disease (HP:0006530) | 2.54862254 |
| 53 | Combined immunodeficiency (HP:0005387) | 2.52564510 |
| 54 | Distal lower limb amyotrophy (HP:0008944) | 2.51033913 |
| 55 | Neurofibrillary tangles (HP:0002185) | 2.47535650 |
| 56 | J-shaped sella turcica (HP:0002680) | 2.44741428 |
| 57 | Vertebral compression fractures (HP:0002953) | 2.44492832 |
| 58 | Neoplasm of striated muscle (HP:0009728) | 2.42756088 |
| 59 | Broad face (HP:0000283) | 2.40592919 |
| 60 | Reduced antithrombin III activity (HP:0001976) | 2.40273491 |
| 61 | Cheilitis (HP:0100825) | 2.38593084 |
| 62 | Periauricular skin pits (HP:0100277) | 2.36855616 |
| 63 | Preauricular pit (HP:0004467) | 2.36855616 |
| 64 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.36535197 |
| 65 | Recurrent fungal infections (HP:0002841) | 2.36167097 |
| 66 | Ragged-red muscle fibers (HP:0003200) | 2.34584779 |
| 67 | Trismus (HP:0000211) | 2.32438710 |
| 68 | Nuclear cataract (HP:0100018) | 2.32381726 |
| 69 | Abnormal cartilage morphology (HP:0002763) | 2.31469465 |
| 70 | Abnormality of the fovea (HP:0000493) | 2.30871328 |
| 71 | Nasolacrimal duct obstruction (HP:0000579) | 2.29298571 |
| 72 | Abnormality of the corticospinal tract (HP:0002492) | 2.27218352 |
| 73 | Increased IgM level (HP:0003496) | 2.27030565 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 2.25402027 |
| 75 | Amyotrophic lateral sclerosis (HP:0007354) | 2.24705878 |
| 76 | Myositis (HP:0100614) | 2.22999859 |
| 77 | Large earlobe (HP:0009748) | 2.22070974 |
| 78 | Hypochromic anemia (HP:0001931) | 2.21972757 |
| 79 | Difficulty running (HP:0009046) | 2.21782434 |
| 80 | Cerebral aneurysm (HP:0004944) | 2.20279712 |
| 81 | Preauricular skin tag (HP:0000384) | 2.20185925 |
| 82 | Increased serum ferritin (HP:0003281) | 2.19629627 |
| 83 | Increased serum pyruvate (HP:0003542) | 2.18268874 |
| 84 | Abnormality of glycolysis (HP:0004366) | 2.18268874 |
| 85 | Distal lower limb muscle weakness (HP:0009053) | 2.17431397 |
| 86 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.17400131 |
| 87 | 3-Methylglutaconic aciduria (HP:0003535) | 2.16217309 |
| 88 | Thin bony cortex (HP:0002753) | 2.16173916 |
| 89 | Petechiae (HP:0000967) | 2.13242632 |
| 90 | Fasciculations (HP:0002380) | 2.12555072 |
| 91 | Colitis (HP:0002583) | 2.11650212 |
| 92 | Polygenic inheritance (HP:0010982) | 2.09455192 |
| 93 | Amyloidosis (HP:0011034) | 2.08185331 |
| 94 | Meningitis (HP:0001287) | 2.06962951 |
| 95 | Prolonged bleeding time (HP:0003010) | 2.06802703 |
| 96 | Gastrointestinal inflammation (HP:0004386) | 2.06788089 |
| 97 | Gingivitis (HP:0000230) | 2.06760066 |
| 98 | Hemorrhage of the eye (HP:0011885) | 2.06366838 |
| 99 | Horizontal nystagmus (HP:0000666) | 2.06320581 |
| 100 | Increased connective tissue (HP:0009025) | 2.06045343 |
| 101 | Cerebral inclusion bodies (HP:0100314) | 2.05723125 |
| 102 | Villous atrophy (HP:0011473) | 2.05475399 |
| 103 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.05475399 |
| 104 | Hepatosplenomegaly (HP:0001433) | 2.05436979 |
| 105 | Peritonitis (HP:0002586) | 2.05163115 |
| 106 | Recurrent viral infections (HP:0004429) | 2.04939443 |
| 107 | Cellulitis (HP:0100658) | 2.04403659 |
| 108 | Personality changes (HP:0000751) | 2.04185649 |
| 109 | Hyperacusis (HP:0010780) | 2.03890575 |
| 110 | Achilles tendon contracture (HP:0001771) | 2.03055385 |
| 111 | Thoracic kyphosis (HP:0002942) | 2.02398744 |
| 112 | Spontaneous hematomas (HP:0007420) | 2.02069201 |
| 113 | Gastrointestinal infarctions (HP:0005244) | 2.02010846 |
| 114 | Purpura (HP:0000979) | 2.01748768 |
| 115 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01402004 |
| 116 | Cerebral hypomyelination (HP:0006808) | 2.00599228 |
| 117 | Glomerulonephritis (HP:0000099) | 2.00588762 |
| 118 | Epistaxis (HP:0000421) | 1.99673005 |
| 119 | Rhabdomyosarcoma (HP:0002859) | 1.99646598 |
| 120 | Stomatitis (HP:0010280) | 1.99190968 |
| 121 | Loss of speech (HP:0002371) | 1.98954727 |
| 122 | Chronic otitis media (HP:0000389) | 1.98688196 |
| 123 | Poor head control (HP:0002421) | 1.98410554 |
| 124 | Retrobulbar optic neuritis (HP:0100654) | 1.97992047 |
| 125 | Optic neuritis (HP:0100653) | 1.97992047 |
| 126 | Prominent occiput (HP:0000269) | 1.96815760 |
| 127 | Bifid tongue (HP:0010297) | 1.96438820 |
| 128 | Panhypogammaglobulinemia (HP:0003139) | 1.96053333 |
| 129 | Premature loss of primary teeth (HP:0006323) | 1.95963755 |
| 130 | Diminished motivation (HP:0000745) | 1.95401396 |
| 131 | Embryonal renal neoplasm (HP:0011794) | 1.95366421 |
| 132 | Orchitis (HP:0100796) | 1.94905320 |
| 133 | Cervical subluxation (HP:0003308) | 1.93572054 |
| 134 | Generalized hypotonia (HP:0001290) | 1.93030791 |
| 135 | Elevated alkaline phosphatase (HP:0003155) | 1.92844332 |
| 136 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.92371349 |
| 137 | Neuronal loss in central nervous system (HP:0002529) | 1.92188237 |
| 138 | Slow saccadic eye movements (HP:0000514) | 1.89131365 |
| 139 | Short humerus (HP:0005792) | 1.88902128 |
| 140 | Abnormal lung lobation (HP:0002101) | 1.87481673 |
| 141 | Difficulty walking (HP:0002355) | 1.87463652 |
| 142 | Joint stiffness (HP:0001387) | 1.87039080 |
| 143 | Skin tags (HP:0010609) | 1.86899101 |
| 144 | Recurrent skin infections (HP:0001581) | 1.86734510 |
| 145 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.86225398 |
| 146 | Bone pain (HP:0002653) | 1.85782157 |
| 147 | Abnormality of the thoracic spine (HP:0100711) | 1.85464474 |
| 148 | Urticaria (HP:0001025) | 1.85368184 |
| 149 | Inflammation of the large intestine (HP:0002037) | 1.85224642 |
| 150 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.85192927 |
| 151 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.84061801 |
| 152 | Cholecystitis (HP:0001082) | 1.83943662 |
| 153 | Abnormal gallbladder physiology (HP:0012438) | 1.83943662 |
| 154 | Progressive muscle weakness (HP:0003323) | 1.83861062 |
| 155 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83673525 |
| 156 | Apathy (HP:0000741) | 1.83042259 |
| 157 | Tetraplegia (HP:0002445) | 1.83008238 |
| 158 | Flat acetabular roof (HP:0003180) | 1.82161821 |
| 159 | Hypertensive crisis (HP:0100735) | 1.81878769 |
| 160 | Hypertriglyceridemia (HP:0002155) | 1.81524419 |
| 161 | Hypergammaglobulinemia (HP:0010702) | 1.81471110 |
| 162 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.81251568 |
| 163 | Obstructive sleep apnea (HP:0002870) | 1.80461919 |
| 164 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.79703917 |
| 165 | Chest pain (HP:0100749) | 1.77017191 |
| 166 | Metaphyseal cupping (HP:0003021) | 1.76385757 |
| 167 | Vasculitis (HP:0002633) | 1.75780750 |
| 168 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.73972889 |
| 169 | Reticulocytosis (HP:0001923) | 1.73094532 |
| 170 | Prolonged neonatal jaundice (HP:0006579) | 1.72503686 |
| 171 | Asymmetric septal hypertrophy (HP:0001670) | 1.72355532 |
| 172 | Granulocytopenia (HP:0001913) | 1.72277805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 6.02450389 |
| 2 | ERN1 | 4.97371412 |
| 3 | GRK5 | 3.99921229 |
| 4 | GRK6 | 3.83168385 |
| 5 | CSF1R | 3.57111133 |
| 6 | TGFBR2 | 3.47627353 |
| 7 | TRIB3 | 3.18340914 |
| 8 | ADRBK2 | 2.88809498 |
| 9 | STK10 | 2.67969233 |
| 10 | GRK7 | 2.63920483 |
| 11 | GRK1 | 2.45922343 |
| 12 | SIK1 | 2.37851069 |
| 13 | MATK | 2.21878153 |
| 14 | EPHB1 | 2.15608595 |
| 15 | MAPK7 | 2.13537835 |
| 16 | TYRO3 | 2.10053286 |
| 17 | SMG1 | 2.02539591 |
| 18 | MAP2K3 | 2.02187124 |
| 19 | RIPK1 | 1.95938121 |
| 20 | MAP3K11 | 1.90418806 |
| 21 | MOS | 1.88731303 |
| 22 | WNK1 | 1.85886737 |
| 23 | BLK | 1.80623832 |
| 24 | PAK4 | 1.78560502 |
| 25 | TESK1 | 1.74805668 |
| 26 | NME2 | 1.68495426 |
| 27 | CSK | 1.57569339 |
| 28 | TAOK1 | 1.57248444 |
| 29 | MAP4K1 | 1.51230218 |
| 30 | TTN | 1.48137634 |
| 31 | TNK2 | 1.46717008 |
| 32 | SIK3 | 1.46456577 |
| 33 | MAP3K3 | 1.44873254 |
| 34 | TAOK2 | 1.43905880 |
| 35 | KIT | 1.40947314 |
| 36 | MARK2 | 1.39514399 |
| 37 | TESK2 | 1.35248636 |
| 38 | TBK1 | 1.33392052 |
| 39 | NTRK1 | 1.31278814 |
| 40 | TYK2 | 1.28059887 |
| 41 | CDC42BPA | 1.25520574 |
| 42 | MST4 | 1.23311936 |
| 43 | MAP3K10 | 1.21358469 |
| 44 | PRKG2 | 1.20890839 |
| 45 | IKBKB | 1.19668157 |
| 46 | CAMK4 | 1.19626043 |
| 47 | TTK | 1.16031547 |
| 48 | FES | 1.13076402 |
| 49 | MAP3K6 | 1.09881310 |
| 50 | MAP3K1 | 1.09728966 |
| 51 | PKN2 | 1.05120126 |
| 52 | SIK2 | 1.02368991 |
| 53 | STK39 | 1.01796014 |
| 54 | ITK | 1.01306852 |
| 55 | RIPK4 | 0.96909832 |
| 56 | PTK6 | 0.95765061 |
| 57 | CLK1 | 0.94350931 |
| 58 | ZAP70 | 0.93164122 |
| 59 | PBK | 0.88092371 |
| 60 | HIPK2 | 0.86511848 |
| 61 | MST1R | 0.85407899 |
| 62 | KSR2 | 0.83483927 |
| 63 | FGFR3 | 0.83227519 |
| 64 | EEF2K | 0.81048872 |
| 65 | HCK | 0.78057365 |
| 66 | ARAF | 0.77994448 |
| 67 | IRAK4 | 0.76837153 |
| 68 | OXSR1 | 0.75281275 |
| 69 | DYRK1B | 0.74671843 |
| 70 | IKBKE | 0.73901716 |
| 71 | CDK7 | 0.72404434 |
| 72 | MAPK12 | 0.71569342 |
| 73 | RPS6KC1 | 0.69691594 |
| 74 | RPS6KL1 | 0.69691594 |
| 75 | PDPK1 | 0.69476514 |
| 76 | RPS6KA2 | 0.69456907 |
| 77 | MAP3K7 | 0.68595153 |
| 78 | ADRBK1 | 0.68186489 |
| 79 | FGR | 0.64431635 |
| 80 | LCK | 0.61462091 |
| 81 | MAP3K14 | 0.61306495 |
| 82 | PKN1 | 0.59801600 |
| 83 | PRKD3 | 0.57141794 |
| 84 | PRPF4B | 0.56804442 |
| 85 | MET | 0.56467915 |
| 86 | LRRK2 | 0.55807395 |
| 87 | MAPK11 | 0.55781318 |
| 88 | BMX | 0.55432211 |
| 89 | PIM2 | 0.54086107 |
| 90 | PRKCD | 0.53752777 |
| 91 | PDGFRA | 0.52376662 |
| 92 | MAPKAPK5 | 0.51640631 |
| 93 | STK38 | 0.51253868 |
| 94 | CAMKK1 | 0.50911949 |
| 95 | ERBB2 | 0.49182900 |
| 96 | RPS6KA6 | 0.48589392 |
| 97 | BTK | 0.47516170 |
| 98 | CDK4 | 0.47213223 |
| 99 | EPHA2 | 0.46632743 |
| 100 | IGF1R | 0.46346498 |
| 101 | STK4 | 0.46178215 |
| 102 | MAP2K6 | 0.46024093 |
| 103 | PAK1 | 0.45609093 |
| 104 | DDR2 | 0.45190460 |
| 105 | RET | 0.44882265 |
| 106 | IRAK2 | 0.43789260 |
| 107 | SYK | 0.43249394 |
| 108 | MAPKAPK2 | 0.43065729 |
| 109 | MAPKAPK3 | 0.39667224 |
| 110 | INSR | 0.39097067 |
| 111 | MAP3K8 | 0.39064169 |
| 112 | GSK3A | 0.37559333 |
| 113 | PRKCQ | 0.37412977 |
| 114 | TRPM7 | 0.37033760 |
| 115 | LYN | 0.36966545 |
| 116 | TXK | 0.35386539 |
| 117 | ICK | 0.34231407 |
| 118 | EIF2AK2 | 0.33632373 |
| 119 | CHUK | 0.32299328 |
| 120 | CAMK1D | 0.32194208 |
| 121 | KDR | 0.32076366 |
| 122 | ABL1 | 0.31713787 |
| 123 | MAP2K2 | 0.31688669 |
| 124 | EGFR | 0.30774990 |
| 125 | MAP3K13 | 0.29431971 |
| 126 | PRKCH | 0.29381252 |
| 127 | IRAK3 | 0.28049197 |
| 128 | FGFR4 | 0.27184534 |
| 129 | PTK2 | 0.27090123 |
| 130 | LIMK1 | 0.27053824 |
| 131 | ALK | 0.27037904 |
| 132 | JAK1 | 0.26836200 |
| 133 | PRKD1 | 0.26630506 |
| 134 | PDK1 | 0.25497013 |
| 135 | FYN | 0.25259778 |
| 136 | JAK2 | 0.25192576 |
| 137 | MAPK4 | 0.25153331 |
| 138 | JAK3 | 0.25126723 |
| 139 | CDK19 | 0.24622657 |
| 140 | MARK3 | 0.23722930 |
| 141 | PRKD2 | 0.22346341 |
| 142 | AKT3 | 0.21947972 |
| 143 | MTOR | 0.21513423 |
| 144 | SRC | 0.21174709 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 5.18923936 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 4.69758906 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.71291515 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.49833391 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.35065125 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.34481927 |
| 7 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.31826595 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23418984 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.23414182 |
| 10 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 2.20703516 |
| 11 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.14375086 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.13322307 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81234117 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.75241460 |
| 15 | Pertussis_Homo sapiens_hsa05133 | 1.67981141 |
| 16 | Malaria_Homo sapiens_hsa05144 | 1.62820249 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.61505654 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61368111 |
| 19 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.60959008 |
| 20 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.59822630 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.56945325 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.52297246 |
| 23 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.43761789 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.43237221 |
| 25 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.42947038 |
| 26 | Bladder cancer_Homo sapiens_hsa05219 | 1.42131671 |
| 27 | Legionellosis_Homo sapiens_hsa05134 | 1.38333849 |
| 28 | Allograft rejection_Homo sapiens_hsa05330 | 1.37478766 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.35719821 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34281293 |
| 31 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.32836765 |
| 32 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.31936315 |
| 33 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31318038 |
| 34 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.30646246 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.26290365 |
| 36 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.24687977 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.20231807 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19563755 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.17864278 |
| 40 | Endometrial cancer_Homo sapiens_hsa05213 | 1.13824545 |
| 41 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.12596621 |
| 42 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10766903 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.09791121 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.09578747 |
| 45 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.09177703 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.08848564 |
| 47 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.06510643 |
| 48 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.05138880 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 1.03415386 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.02968589 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02770637 |
| 52 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.01045287 |
| 53 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.98906378 |
| 54 | Measles_Homo sapiens_hsa05162 | 0.95247364 |
| 55 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95161603 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.92560115 |
| 57 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.90122354 |
| 58 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90036155 |
| 59 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.89785101 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.89276037 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.86320059 |
| 62 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86292991 |
| 63 | Platelet activation_Homo sapiens_hsa04611 | 0.85873154 |
| 64 | Phagosome_Homo sapiens_hsa04145 | 0.85202037 |
| 65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83732254 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.82729075 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82014345 |
| 68 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.81889010 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.81802334 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.81010696 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.79609566 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78585645 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78528812 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.77811352 |
| 75 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77560547 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.77091373 |
| 77 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.76228990 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.74015205 |
| 79 | Hepatitis C_Homo sapiens_hsa05160 | 0.73994873 |
| 80 | Salmonella infection_Homo sapiens_hsa05132 | 0.73015422 |
| 81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72709907 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71643230 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69865688 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69551257 |
| 85 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.68219181 |
| 86 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.67452871 |
| 87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67263743 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.67189957 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.66686311 |
| 90 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.66271457 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66260618 |
| 92 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64444673 |
| 93 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.64301105 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.64058082 |
| 95 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64040825 |
| 96 | Prion diseases_Homo sapiens_hsa05020 | 0.63102253 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.62945424 |
| 98 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62596524 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.62460937 |
| 100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.61825074 |
| 101 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60850165 |
| 102 | Insulin resistance_Homo sapiens_hsa04931 | 0.60581058 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.60295265 |
| 104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59123403 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.58298888 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.58150573 |
| 107 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57761938 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.57334874 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.57076953 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.55696016 |
| 111 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54740508 |
| 112 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54672026 |
| 113 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.54446829 |
| 114 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54365882 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.53873529 |
| 116 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52844966 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51293727 |
| 118 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50741504 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49776431 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.49543152 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49434181 |
| 122 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48930981 |
| 123 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48293365 |
| 124 | Asthma_Homo sapiens_hsa05310 | 0.48174259 |
| 125 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.47630382 |
| 126 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44036112 |
| 127 | Pathways in cancer_Homo sapiens_hsa05200 | 0.40963142 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40278077 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.34571718 |
| 130 | Histidine metabolism_Homo sapiens_hsa00340 | 0.31204180 |
| 131 | ABC transporters_Homo sapiens_hsa02010 | 0.29356309 |
| 132 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27145285 |
| 133 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.26508891 |
| 134 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.25467169 |
| 135 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.25415735 |
| 136 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.23491376 |

